We are excited to announce Breakthrough Device Designation for our?neuro?Optical Coherence Tomography (nOCT) technology from the FDA.?We are also pleased to share that Spryte Medical is included in the FDA’s new Total Product Life Cycle Advisory Program (TAP).?These represent important milestones on our path toward bringing?nOCT to neurovascular care. ? Please visit our new website to learn more about Spryte Medical and?nOCT: Spryte Website: https://sprytemedical.com/ Press Release: https://lnkd.in/eszPqmMT #nOCT #neuroOCT
Spryte Medical
医疗设备制造业
Bedford，Massachusetts 811 位关注者
Advancing cerebrovascular care through groundbreaking neuro intravascular imaging and AI technologies.
关于我们
Advancing cerebrovascular care through groundbreaking neuro intravascular imaging and AI technologies.
- 网站
-
https://sprytemedical.com
Spryte Medical的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Bedford，Massachusetts
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
获取路线
4 Crosby Dr
Suite 4.2
US，Massachusetts，Bedford，01730
Spryte Medical员工
-
Vlad Zilberman
Vice President of Operations at Spryte Medical
-
Renny Clark
Executive Vice President and CFO of Gentuity, LLC, Spryte Medical, Inc. and New England Cell Therapeutics, Inc.
-
Matthew Brinkman
Clinical and Upstream Marketing Professional
-
Mark Calderan
Director of Finance at Gentuity, LLC and Spryte Medical Inc.